Botulinum toxin in post-stroke patients: Stiffness modifications and clinical implications

Giacinta Miscio, Carmen Del Conte, Danilo Pianca, Roberto Colombo, Marcela Panizza, Marco Schieppati, Fabrizio Pisano

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objective: To objectively quantify stiffness and clinical changes in the upper limb of post-stroke patients following botulinum toxin (BT) injection. Methods: Eighteen consecutive chronic post-stroke spastic patients were injected Botulinum toxin A in the forearm flexor spastic muscles. Spasticity was clinically evaluated with the Ashworth scale. Stiffness was measured with indices (passive stiffness index (ISI) and total stiffness index (TSI) obtained by mechanical wrist displacements induced by a torque motor, which could also provide the stretch reflex threshold speed (SRTS) from flexor muscles. Functional status was measured with the Barthel index and a specific hand ability scale, pain with a visual analogue scale (VAS). The ranges of voluntary wrist extension (EROM) and flexion (FROM) and wrist isometric extension and flexion (IE - IF) strength were also calculated. Results: IE and EROM significantly increased, being respectively p <0.01 and p <0.05; also SRTS was augmented (p <0.001), while TSI showed lower values (p <0.001) ; the Ashworth score decreased at least one point. Hand function for selected tasks improved in 50% of patients, the Barthel index only in 4 (22%), forearm pain was completely relieved in 3 patients (17%). Conclusions: BT can be considered a valid therapeutic tool in all spastic patients, because of immediate advantages: reduction of muscle hypertonia, pain relief, improvement in selected motor performances.

Original languageEnglish
Pages (from-to)189-196
Number of pages8
JournalJournal of Neurology
Volume251
Issue number2
DOIs
Publication statusPublished - Feb 2004

Fingerprint

Botulinum Toxins
Stroke
Muscle Spasticity
Wrist
Stretch Reflex
Forearm
Hand
Muscle Hypertonia
Pain
Muscles
Type A Botulinum Toxins
Aptitude
Myalgia
Torque
Visual Analog Scale
Upper Extremity
Injections

Keywords

  • Botulinum toxin
  • Spasticity
  • Stiffness
  • Stretch reflex
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Botulinum toxin in post-stroke patients : Stiffness modifications and clinical implications. / Miscio, Giacinta; Del Conte, Carmen; Pianca, Danilo; Colombo, Roberto; Panizza, Marcela; Schieppati, Marco; Pisano, Fabrizio.

In: Journal of Neurology, Vol. 251, No. 2, 02.2004, p. 189-196.

Research output: Contribution to journalArticle

@article{940302eb546e40fbb6d55c0cc6860708,
title = "Botulinum toxin in post-stroke patients: Stiffness modifications and clinical implications",
abstract = "Objective: To objectively quantify stiffness and clinical changes in the upper limb of post-stroke patients following botulinum toxin (BT) injection. Methods: Eighteen consecutive chronic post-stroke spastic patients were injected Botulinum toxin A in the forearm flexor spastic muscles. Spasticity was clinically evaluated with the Ashworth scale. Stiffness was measured with indices (passive stiffness index (ISI) and total stiffness index (TSI) obtained by mechanical wrist displacements induced by a torque motor, which could also provide the stretch reflex threshold speed (SRTS) from flexor muscles. Functional status was measured with the Barthel index and a specific hand ability scale, pain with a visual analogue scale (VAS). The ranges of voluntary wrist extension (EROM) and flexion (FROM) and wrist isometric extension and flexion (IE - IF) strength were also calculated. Results: IE and EROM significantly increased, being respectively p <0.01 and p <0.05; also SRTS was augmented (p <0.001), while TSI showed lower values (p <0.001) ; the Ashworth score decreased at least one point. Hand function for selected tasks improved in 50{\%} of patients, the Barthel index only in 4 (22{\%}), forearm pain was completely relieved in 3 patients (17{\%}). Conclusions: BT can be considered a valid therapeutic tool in all spastic patients, because of immediate advantages: reduction of muscle hypertonia, pain relief, improvement in selected motor performances.",
keywords = "Botulinum toxin, Spasticity, Stiffness, Stretch reflex, Stroke",
author = "Giacinta Miscio and {Del Conte}, Carmen and Danilo Pianca and Roberto Colombo and Marcela Panizza and Marco Schieppati and Fabrizio Pisano",
year = "2004",
month = "2",
doi = "10.1007/s00415-004-0297-3",
language = "English",
volume = "251",
pages = "189--196",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "2",

}

TY - JOUR

T1 - Botulinum toxin in post-stroke patients

T2 - Stiffness modifications and clinical implications

AU - Miscio, Giacinta

AU - Del Conte, Carmen

AU - Pianca, Danilo

AU - Colombo, Roberto

AU - Panizza, Marcela

AU - Schieppati, Marco

AU - Pisano, Fabrizio

PY - 2004/2

Y1 - 2004/2

N2 - Objective: To objectively quantify stiffness and clinical changes in the upper limb of post-stroke patients following botulinum toxin (BT) injection. Methods: Eighteen consecutive chronic post-stroke spastic patients were injected Botulinum toxin A in the forearm flexor spastic muscles. Spasticity was clinically evaluated with the Ashworth scale. Stiffness was measured with indices (passive stiffness index (ISI) and total stiffness index (TSI) obtained by mechanical wrist displacements induced by a torque motor, which could also provide the stretch reflex threshold speed (SRTS) from flexor muscles. Functional status was measured with the Barthel index and a specific hand ability scale, pain with a visual analogue scale (VAS). The ranges of voluntary wrist extension (EROM) and flexion (FROM) and wrist isometric extension and flexion (IE - IF) strength were also calculated. Results: IE and EROM significantly increased, being respectively p <0.01 and p <0.05; also SRTS was augmented (p <0.001), while TSI showed lower values (p <0.001) ; the Ashworth score decreased at least one point. Hand function for selected tasks improved in 50% of patients, the Barthel index only in 4 (22%), forearm pain was completely relieved in 3 patients (17%). Conclusions: BT can be considered a valid therapeutic tool in all spastic patients, because of immediate advantages: reduction of muscle hypertonia, pain relief, improvement in selected motor performances.

AB - Objective: To objectively quantify stiffness and clinical changes in the upper limb of post-stroke patients following botulinum toxin (BT) injection. Methods: Eighteen consecutive chronic post-stroke spastic patients were injected Botulinum toxin A in the forearm flexor spastic muscles. Spasticity was clinically evaluated with the Ashworth scale. Stiffness was measured with indices (passive stiffness index (ISI) and total stiffness index (TSI) obtained by mechanical wrist displacements induced by a torque motor, which could also provide the stretch reflex threshold speed (SRTS) from flexor muscles. Functional status was measured with the Barthel index and a specific hand ability scale, pain with a visual analogue scale (VAS). The ranges of voluntary wrist extension (EROM) and flexion (FROM) and wrist isometric extension and flexion (IE - IF) strength were also calculated. Results: IE and EROM significantly increased, being respectively p <0.01 and p <0.05; also SRTS was augmented (p <0.001), while TSI showed lower values (p <0.001) ; the Ashworth score decreased at least one point. Hand function for selected tasks improved in 50% of patients, the Barthel index only in 4 (22%), forearm pain was completely relieved in 3 patients (17%). Conclusions: BT can be considered a valid therapeutic tool in all spastic patients, because of immediate advantages: reduction of muscle hypertonia, pain relief, improvement in selected motor performances.

KW - Botulinum toxin

KW - Spasticity

KW - Stiffness

KW - Stretch reflex

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=1242269907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242269907&partnerID=8YFLogxK

U2 - 10.1007/s00415-004-0297-3

DO - 10.1007/s00415-004-0297-3

M3 - Article

C2 - 14991354

AN - SCOPUS:1242269907

VL - 251

SP - 189

EP - 196

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 2

ER -